AR026487A1 - Derivados de espiro[2h-1-benzopiran-2,4'-piperidina] para el uso en terapia, especificamente para el tratamiento de alteraciones del snc - Google Patents
Derivados de espiro[2h-1-benzopiran-2,4'-piperidina] para el uso en terapia, especificamente para el tratamiento de alteraciones del sncInfo
- Publication number
- AR026487A1 AR026487A1 ARP000106034A ARP000106034A AR026487A1 AR 026487 A1 AR026487 A1 AR 026487A1 AR P000106034 A ARP000106034 A AR P000106034A AR P000106034 A ARP000106034 A AR P000106034A AR 026487 A1 AR026487 A1 AR 026487A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- optionally substituted
- hydrogen
- derivatives
- piperidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Derivados de espiro[2H-1-benzopiran-2,4-piperidina] que tienen la formula general (1) donde la línea de puntos representa un enlace opcional; Y representa1-4 sustituyentes seleccionados independientemente entre hidrogeno, halogeno, alquilo C1-6 (opci onalmente sustituido con uno o más halogenos), alquiloxi C1-6(opcionalmente sustituido con uno o más halogenos o con cicloalquilo C3-6), alqueniloxi C2-6, alquiniloxi C2-6, cicloalquiloxi C3-6, ariloxi C6-12,arilalquiloxi, heteroariloxi, heteroarilal quiloxi, SR3, NR3R4, OSO2R5 y NR3SO2R4; 2 sustituyentes Y pueden formar juntos O-(CH2)n-O u O-(CF2)n-O, donde n es 1o 2; o bien Y representa un grupo arilo C5-6 fusionado; X representa 1-3 sustituyentes seleccionados independientemente entre hidrogen o, halogeno, hidroxi,alquiloxi C1-4, SR3, NR3SO2R4 y alquilo C1-4, opcionalmente sustituido con halogeno; R1 es hidrogeno, alquilo C1-4 o arilo C6-12; R2, R3 y R4 sonindependientemente hidrogeno o alquilo C1-4; R5 es alquilo C1-4 (opcionalmente susti tuido con uno o más halogenos) o arilo C6-12 (opcionalmente sustituido conalquilo C1-4); o una sal farmacéuticamente aceptable del mismo. Composiciones farmacéuticas que comprenden dichos derivados. Uso de estos derivados deespiro[2H-1-benzopiran-2,4 -piperidina] para preparar un medicamento. Estos compuestos que alteran la actividad de los transportadores de glicina provocancambios en los tejidos pudiendo ser utiles en el tratamiento de trastornos asociados a la funcion disminuida o exagerada de los receptores de NMDA, comopsicosis, depresion, demencia y también otras como la enfermedad de Alzheimer, Parkinson, espasticidad y epilepsia. También pueden tener propiedadesanalgésicas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99309137 | 1999-11-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR026487A1 true AR026487A1 (es) | 2003-02-12 |
Family
ID=8241739
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP000106034A AR026487A1 (es) | 1999-11-17 | 2000-11-16 | Derivados de espiro[2h-1-benzopiran-2,4'-piperidina] para el uso en terapia, especificamente para el tratamiento de alteraciones del snc |
Country Status (29)
| Country | Link |
|---|---|
| US (2) | US6645973B1 (es) |
| EP (1) | EP1232160B1 (es) |
| JP (1) | JP4825386B2 (es) |
| KR (1) | KR100776226B1 (es) |
| CN (1) | CN1199974C (es) |
| AR (1) | AR026487A1 (es) |
| AT (1) | ATE398622T1 (es) |
| AU (1) | AU779518B2 (es) |
| BR (1) | BR0015586A (es) |
| CA (1) | CA2389491C (es) |
| CO (1) | CO5261618A1 (es) |
| CY (1) | CY1108339T1 (es) |
| CZ (1) | CZ293920B6 (es) |
| DE (1) | DE60039247D1 (es) |
| DK (1) | DK1232160T3 (es) |
| ES (1) | ES2307536T3 (es) |
| HK (1) | HK1047282B (es) |
| HU (1) | HUP0204162A3 (es) |
| IL (2) | IL149286A0 (es) |
| NO (1) | NO327743B1 (es) |
| NZ (1) | NZ518671A (es) |
| PE (1) | PE20010750A1 (es) |
| PL (1) | PL206071B1 (es) |
| PT (1) | PT1232160E (es) |
| RU (1) | RU2250211C2 (es) |
| SK (1) | SK287040B6 (es) |
| TW (1) | TWI243173B (es) |
| WO (1) | WO2001036423A1 (es) |
| ZA (1) | ZA200203320B (es) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI243173B (en) * | 1999-11-17 | 2005-11-11 | Akzo Nobel Nv | Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives |
| FR2842804B1 (fr) * | 2002-07-29 | 2004-09-03 | Sanofi Synthelabo | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
| JP4976134B2 (ja) * | 2003-10-01 | 2012-07-18 | アドラー コーポレーション | スピロ環複素環誘導体及びそれらを使用する方法 |
| BRPI0418375A (pt) * | 2004-01-08 | 2007-05-22 | Hoffmann La Roche | derivados de diaza-espiropiperidina |
| RU2351599C2 (ru) * | 2004-01-08 | 2009-04-10 | Ф.Хоффманн-Ля Рош Аг | Диазаспиропиперидиновые производные в качестве ингибиторов глицинового переносчика 1 и глицинового переносчика 2 |
| US20050209317A1 (en) * | 2004-03-22 | 2005-09-22 | Apkarian A V | Method and compositions for treatment of chronic neuropathic pain |
| US7598261B2 (en) * | 2005-03-31 | 2009-10-06 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| CN101184749B (zh) * | 2005-03-31 | 2012-12-05 | 阿得罗公司 | 螺环杂环衍生物及其使用方法 |
| US7576207B2 (en) * | 2006-04-06 | 2009-08-18 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| CA2648831A1 (en) * | 2006-05-05 | 2007-11-15 | Ulrich Reiser | Spiro- (tho) benzopyran-2, 4' -piperidine-and cyclohexane derivatives as inhibitors of specific cell cycle enzymes |
| CN101534819A (zh) * | 2006-09-12 | 2009-09-16 | 阿得罗公司 | 含氮的螺环化合物用于增强认知功能的应用 |
| TWI366565B (en) | 2007-06-06 | 2012-06-21 | Otsuka Pharma Co Ltd | Quinolone compound and pharmaceutical composition |
| KR100888468B1 (ko) * | 2007-08-31 | 2009-03-11 | 한국화학연구원 | 항암활성을 갖는1'-알킬피페리딘-4'-스피로-2-6-(아미도)-2ｈ-벤조피란유도체 |
| US20100317679A1 (en) * | 2007-09-21 | 2010-12-16 | Ligand Pharmaceuticals, Inc. | Substituted aryl-fused spirocyclic amines |
| EP2380595A1 (en) | 2010-04-19 | 2011-10-26 | Nlife Therapeutics S.L. | Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types |
| TWI543984B (zh) * | 2010-07-09 | 2016-08-01 | 艾伯維公司 | 作為s1p調節劑的螺-哌啶衍生物 |
| US20170143681A1 (en) | 2015-11-02 | 2017-05-25 | Apkarian Technologies Llc | Methods and compositions for treating pain |
| CN116621187B (zh) * | 2023-07-24 | 2023-09-22 | 江苏泓顺硅基半导体科技有限公司 | 一种用于高温氯化提纯石英砂的设备 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ243065A (en) * | 1991-06-13 | 1995-07-26 | Lundbeck & Co As H | Piperidine derivatives and pharmaceutical compositions |
| FR2689509B1 (fr) * | 1992-04-01 | 1994-06-03 | Adir | Nouveaux derives spiraniques du 3-amino chromane, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
| DK78692D0 (da) * | 1992-06-12 | 1992-06-12 | Lundbeck & Co As H | Dimere piperidin- og piperazinderivater |
| IL107881A0 (en) * | 1992-12-05 | 1994-04-12 | Fisons Corp | Furanone derivatives and pharmaceutical compositions containing them |
| WO1994018204A1 (en) * | 1993-02-12 | 1994-08-18 | Merck & Co., Inc. | Spiro (2h-1-benzopyran-2, 4' piperidine) class iii antiarrhythmics |
| US5484923A (en) * | 1993-06-10 | 1996-01-16 | Merck & Co., Inc. | Process of making spirocycles and analogs thereof |
| US5439914A (en) * | 1994-02-18 | 1995-08-08 | Merck & Co., Inc. | Spirocycles |
| GB9421003D0 (en) * | 1994-10-18 | 1994-12-07 | Smithkline Beecham Plc | Novel compounds |
| US5654316A (en) | 1995-06-06 | 1997-08-05 | Schering Corporation | Piperidine derivatives as neurokinin antagonists |
| PT871440E (pt) | 1995-12-07 | 2006-07-31 | Daniel C Javitt | Tratamento de sintomas negativos e cognitivos de esquizofrenia com antagonistas da captacao de glicina |
| HUP9600928A3 (en) * | 1996-04-10 | 1999-03-29 | Richter Gedeon Vegyeszet | Use of spiro[2h-1-benzopyran-2,4'-piperidin]-4(3h)-one derivatives for the preparation of pharmaceutical compositions treating dementia, novel derivatives and process for their preparation |
| DK1014966T3 (da) | 1996-05-31 | 2006-12-04 | Allelix Neuroscience Inc | Farmaceutisk præparat til behandling af neurologiske og neuropsykiatriske lidelser |
| CA2255727A1 (en) | 1996-05-31 | 1997-12-04 | Trophix Pharmaceuticals, Inc. | Pharmaceutical for treating of neurological and neuropsychiatric disorders |
| US5919653A (en) | 1996-08-20 | 1999-07-06 | Allelix Neuroscience Inc. | Nucleic acids encoding a human glycine transporter |
| AU2030999A (en) | 1998-01-09 | 1999-07-26 | Allelix Neuroscience, Inc. | Glycine transport inhibitors |
| TW555757B (en) | 1998-07-31 | 2003-10-01 | Akzo Nobel Nv | Aminomethylcarboxylic acid derivatives |
| TWI243173B (en) * | 1999-11-17 | 2005-11-11 | Akzo Nobel Nv | Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives |
| MXPA02010518A (es) * | 2000-04-27 | 2003-03-10 | Basilea Pharmaceutica Ag | Cromenilmetilpirimidindiaminas como agentes antibacterianos. |
-
2000
- 2000-11-08 TW TW089123584A patent/TWI243173B/zh not_active IP Right Cessation
- 2000-11-13 CA CA2389491A patent/CA2389491C/en not_active Expired - Fee Related
- 2000-11-13 EP EP00977546A patent/EP1232160B1/en not_active Expired - Lifetime
- 2000-11-13 CZ CZ20021724A patent/CZ293920B6/cs not_active IP Right Cessation
- 2000-11-13 NZ NZ518671A patent/NZ518671A/en unknown
- 2000-11-13 AT AT00977546T patent/ATE398622T1/de not_active IP Right Cessation
- 2000-11-13 HU HU0204162A patent/HUP0204162A3/hu unknown
- 2000-11-13 BR BR0015586-1A patent/BR0015586A/pt not_active Application Discontinuation
- 2000-11-13 PL PL355975A patent/PL206071B1/pl not_active IP Right Cessation
- 2000-11-13 AU AU15219/01A patent/AU779518B2/en not_active Ceased
- 2000-11-13 PT PT00977546T patent/PT1232160E/pt unknown
- 2000-11-13 DE DE60039247T patent/DE60039247D1/de not_active Expired - Lifetime
- 2000-11-13 IL IL14928600A patent/IL149286A0/xx active IP Right Grant
- 2000-11-13 ES ES00977546T patent/ES2307536T3/es not_active Expired - Lifetime
- 2000-11-13 SK SK843-2002A patent/SK287040B6/sk not_active IP Right Cessation
- 2000-11-13 RU RU2002115862/04A patent/RU2250211C2/ru not_active IP Right Cessation
- 2000-11-13 JP JP2001538912A patent/JP4825386B2/ja not_active Expired - Fee Related
- 2000-11-13 WO PCT/EP2000/011351 patent/WO2001036423A1/en active Search and Examination
- 2000-11-13 KR KR1020027006305A patent/KR100776226B1/ko not_active IP Right Cessation
- 2000-11-13 US US10/130,557 patent/US6645973B1/en not_active Expired - Lifetime
- 2000-11-13 CN CNB008157901A patent/CN1199974C/zh not_active Expired - Fee Related
- 2000-11-13 DK DK00977546T patent/DK1232160T3/da active
- 2000-11-16 PE PE2000001227A patent/PE20010750A1/es not_active Application Discontinuation
- 2000-11-16 AR ARP000106034A patent/AR026487A1/es unknown
- 2000-11-17 CO CO00087799A patent/CO5261618A1/es not_active Application Discontinuation
-
2002
- 2002-04-23 IL IL149286A patent/IL149286A/en not_active IP Right Cessation
- 2002-04-25 ZA ZA200203320A patent/ZA200203320B/xx unknown
- 2002-05-15 NO NO20022320A patent/NO327743B1/no not_active IP Right Cessation
- 2002-12-11 HK HK02108962.5A patent/HK1047282B/zh not_active IP Right Cessation
-
2003
- 2003-08-08 US US10/637,681 patent/US7507824B2/en not_active Expired - Lifetime
-
2008
- 2008-09-15 CY CY20081100992T patent/CY1108339T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR026487A1 (es) | Derivados de espiro[2h-1-benzopiran-2,4'-piperidina] para el uso en terapia, especificamente para el tratamiento de alteraciones del snc | |
| AR046600A1 (es) | Diazaespiroalcanos y su uso como tratamiento para enfermedades mediadas por ccr8 | |
| ES2309594T3 (es) | Composiciones que contienen bloqueadores de los canales de calcio de tipo l e inhibidores de la colinesterasa. | |
| AR025735A1 (es) | Compuestos terapeuticos | |
| AR033306A1 (es) | Compuestos | |
| ATE398618T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von zns und anderen krankheiten | |
| CO5021129A1 (es) | Nuevos compuestos farmaceuticos derivados de pleuromutilina y metodos para su preparacion | |
| NO306457B1 (no) | 2,4-disulfonylfenylbutylnitron, salter derav, farmasöytisk sammensetning, samt anvendelse av denne forbindelse til fremstilling av et medikament | |
| AR049670A1 (es) | Un derivado de acido aminometil carboxilico, su uso en el tratamiento de alteraciones del snc y una composicion farmaceutica que lo contiene | |
| AR012488A1 (es) | Un compuesto derivado de quino- y quinazolinas antagonistas del factor liberador de corticotropina, un procedimiento para su preparacion, unacomposicion que los comprende, un procedimiento para la preparacion de dicha composicion, intermediarios y el uso de dichos compuestos para la fabricacion | |
| GB2240475A (en) | 5ht-3 antagonist for the prevention or reduction of dependence | |
| MY118163A (en) | Aryl fused azapolycyclic compounds | |
| PA8442201A1 (es) | Derivados de 6-fenilpiridil-2-amina | |
| ES2164889T3 (es) | Semicarbazonas con actividad sobre el snc y preparados farmaceuticos a base de las mismas. | |
| PA8456901A1 (es) | 2-aminopiridinas que contienen sustituyentes de anillos condensados | |
| AR022303A1 (es) | Derivados de piperidina, tetrahidropiridina y piperazina, su preparacion y utilizacion | |
| NO975709D0 (no) | Nye 19-nor-pregnan-steroider for indusering av hypototalamiske effekter | |
| AR004708A1 (es) | Un derivado de 5-fenil-3-(piperidin-4-il)-1,3,4-oxadiazol-2(3h)-ona, un medicamento, una composicion farmaceutica que lo comprende y un procedimiento de preparacion de dicho derivado. | |
| MX2008015860A (es) | Combinaciones que comprenden moduladores de 5ht6 e inhibidores de la colinesterasa. | |
| AR029373A1 (es) | Metodo para el tratamiento de migranas, utilizando compuestos antagonistas selectivos de los receptores iglur5, uso de dichos compuestos antagonistas selectivos en la manufactura de medicamentos para el tratamiento de migranas y dichos compuestos antagonistas | |
| AR045913A1 (es) | Derivados olefinicos de 8-azabiciclo[3,2,1]octanos como antagonistas de receptores muscarinicos de acetilcolina | |
| DE60323369D1 (de) | Zusammensetzung zur behandlung entzündlicher erkrankungen | |
| SK8982000A3 (en) | Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases | |
| AR002717A1 (es) | Compuestos de beta-alanina y sus sales farmaceuticamente aceptables, procedimiento para prepararlos, composiciones farmaceuticas que los contienen ymetodos para tratar trastornos cardiovasculares tales como los causados por la formacion de trombosis, trombocitosis, reemplazo de valvulas o implantes | |
| AR045939A1 (es) | Derivados de bencimidazolona y quinazolinona como agonistas de los receptores orl 1 humanos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |